NEW YORK (GenomeWeb News) — Ventana Medical Systems has offered Roche a glimpse into its financial health as it hopes to convince the Swiss drug and diagnostics giant to spend some more on it than the $3 billion dollars it continues to offer.
Tucson, Ariz.-based Ventana, which has snubbed Roche’s unsolicited bid to acquire it at least four times, said it hopes the due diligence and related talks will “allow Roche to recognize the significant additional value inherent in Ventana's business.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.